January 16, 2018 – Medicinal Genomics Partners with DASH Cryptocurrency for CannMed 2018 Cannabis Conference The 3rd Annual CannMed Conference will join leaders in cannabis research, medicine, and technology to discuss the use of cannabis-based therapies for a variety of medical conditions, innovations in cultivation, and the intersection of cryptocurrency and cannabis.
March 30, 2017 – CannMed 2017 Premier Medical Marijuana Conference to Feature Global Industry Leaders, Physicians, Scientists, Politicians, Athletes, Attorneys, and Media Gathering to Discuss Medicine, Legalization, Opioids vs. Cannabis, Pain Management, and More Conference to Be Live Streamed Including Featured Speakers, Dr. Raphael Mechoulam (The “Father of Cannabis Research”), Dr. Michael Dor, Dr. Bonni Goldstein, and Former NFL Athletes
March 28, 2017 – CannMed 2017 Conference will Host Red-Carpet Event and Screening of Film in Honor of Local Teen with Rare Cancer Local Teenage Patient Fulfilled Dream of Becoming a Filmmaker with Help from Hollywood A-List Actors and Directors and the Make A Film Foundation
March 22, 2017 – CannMed 2017 Conference to Feature Former NFL Players Leading Panel Discussion on Medical Marijuana Use in Professional Sports Former NFL players Ricky Williams, Nate Jackson, Eben Britton, and Lance Johnstone join leading physicians to discuss medical cannabis as a viable alternative to often addictive opiates
February 23, 2017 – Courtagen Receives Notice of Allowance for a Genetically Targeted Pain Therapy Patent in the U.S. Patent targets personalized medicine approach matching genetic markers for chronic pain with therapeutic drugs, including the cannabis-derived compound cannabidiol
February 10, 2017 – CannMed 2017 Conference Announces Expanded Speaker List for Medical Cannabis Health and Research Conference to be Held in Boston in April Leaders in Cannabis Medicine and the Medical Cannabis Industry Join Presenters Including Dr. Raphael Mechoulam, Pioneering Israeli Scientist Known as “The Father of Marijuana Research”
February 3, 2017 – Medicinal Genomics Hosts CannMed 2017 Conference in Boston with Hawaiian Connection International conference at Harvard organized by Manoa Valley resident helps to educate physicians about use of medical cannabis
January 25, 2017 – Medicinal Genomics Receives NIDA Grant to Develop Novel Toxin Detection Test for Medical Cannabis Test development will center around detecting presence of toxic products left behind by rogue molds and bacteria on medical cannabis.
January 12, 2017 – CannMed 2017 Conference to Offer Doctors an Opportunity to Earn CME Credits to Learn About Cannabis Medicine Courtagen and TheAnswerPage partner to provide continuing medical education about the endocannabinoid system and medical cannabis for the CannMed 2017 Personalized Cannabinoid Medicine Conference.
January 9, 2017 – Veterans for Cannabis Foundation and Medicinal Genomics Pair Up to Tackle Medical Marijuana “Strain Name Game” for Vets MGC will provide StrainSEEK™ strain identification and registration services for VFCF’s branded products and help promote the VFCF mission as MGC’s exclusive veteran’s cannabis support partner.
December 1, 2016 – Medicinal Genomics and Courtagen Life Sciences Announce CannMed 2017, the Personalized Cannabinoid Medicine Conference, April 9-11, 2017 The 2nd annual CannMed 2017 Conference will convene leaders in research, medicine, and therapeutics to discuss cannabis-based therapies for cancer, and neurological and inflammatory disorders, and developments in cannabis genetics and safety.
November 15, 2016 – Researchers Find Alarming Pathogenic Contamination Inaccuracies with Commonly Used Culture-Based Cannabis Testing Methods Medicinal Genomics (MGC) and Courtagen Life Sciences today announced the publication of a new research study that identifies several significant shortcomings of traditional culture-based safety testing methods for yeast and mold in the Cannabis industry.
October 6, 2016 – Medicinal Genomics Partners with Industry Leaders to Ensure the Safety and Effectiveness of Medical Cannabis Medicinal Genomics, an innovative molecular information company focused on safety, research, and genetics of therapeutic plants, is partnering with a preliminary group of twelve leading cultivators and processors to develop fully-validated, genomics-based safety and quality standards for medical cannabis.
April 20, 2016 – Medicinal Genomics Revolutionizes Cannabis Industry with Introduction of Strain ID & Certification Service Medicinal Genomics Corporation today announced StrainSEEK™, a revolutionary genetics based service designed to identify and certify cannabis and hemp strains, providing growers with the identity, heritage, and chemistry of the cannabis and hemp plants they are cultivating.
April 6, 2016 – CannMed 2016 Conference to be Live Streamed Including the Keynote Speech by Noted Israeli Marijuana Research Pioneer Dr. Raphael Mechoulam Medicinal Genomics and Courtagen Life Sciences today announced that the entire full day program of CannMed 2016 will be live streamed on Monday, April 11th, 2016.
March 15, 2016 – Dr. Raphael Mechoulam to Receive Lifetime Achievement Award at CannMed 2016 Conference in Cambridge, MA in April Pioneering Israeli Scientist Known as “The Father of Marijuana Research,” Dr. Raphael Mechoulam, to be Honored for Decades of Discoveries.
March 8, 2016 – Courtagen and Medicinal Genomics Announce Expanded Speaker List for CannMed 2016 – 1st Annual Cannabis Medical Research Conference Being Held in Cambridge, MA in April The conference will feature internationally recognized thought leaders, scientists, physicians, and advocates working to advance research into the endocannabinoid system and cannabinoid therapeutics.
February 11, 2016 – CannMed2016 Announces That Kyle Turley, Former NFL Pro Bowler and Leading Cannabis Advocate, Will Speak at 1st Annual Cannabis Medical Research Conference Being Held in Cambridge, MA in April Former All-Pro NFL offensive lineman, Kyle Turley, will be a featured speaker at CannMed2016. This first annual Personalized Cannabinoid Medicine Conference will be held at The Joseph B. Martin Conference Center at The Harvard School of Medicine April 10-11, 2016.
January 13, 2016 – Medicinal Genomics Corporation and Courtagen Life Sciences Announce CannMed 2016, the Personalized Cannabinoid Medicine Conference, April 10-11, 2016 CannMed 2016 Personalized Cannabinoid Medicine Conference will convene leaders in research, medicine, and therapeutics to discuss real-world issues around cannabis-based therapies for neurological disorders
April 16, 2015 – Medicinal Genomics Corporation Launches PathogINDICAtor™, A Novel and Automated Microbial Screening Kit for Cannabis Medicinal Genomics Corporation, a pioneer in the genomics of medicinal plants, today announced the availability of PathogINDICAtor™, a highly robust and automated microbial screening assay for cannabis.
March 31, 2015 – Medicinal Genomics Corporation Launches SenSATIVAx™, A Novel Automated Plant/Microbial DNA Purification Kit for Cannabis Medicinal Genomics Corporation, a pioneer in the genomics of medicinal plants, today announced the availability of SenSATIVAxTM, a highly robust and automated microbial DNA purification kit for Cannabis.
January 12, 2012 – Medicinal Genomics Introduces an iPad App to Explore the Science of Medical Marijuana Medicinal Genomics Corporation, a pioneer in the genomics of medicinal plants, today announced the availability of Jane-Ome, an application designed for Apple’s iPad tablet, which offers a science based dissection of medical marijuana.
January 15, 2011 – Medicinal Genomics Sequences the Cannabis Genome to Assemble the Largest Known Gene Collection of this Therapeutic Plant Medicinal Genomics Corporation, a pioneer in the genomics of medicinal plants, today announced that the company has sequenced the entire genome of Cannabis Sativa and Cannabis Indica, assembling the largest known gene collection of this therapeutic plant. The DNA purification was performed at the company’s research facility in Amsterdam, and the sequencing was conducted by several service providers, including the latest long read technology from Roche’s 454 sequencing center.